QLD Deputy Premier Jarrod Bleijie has officially unveiled the name of Translational Research Institute's Australian-first cGMP biomedical manufacturing facility, nearing completion in Brisbane's Boggo Road Innovation Precinct.
The facility has been named ENTRI, acknowledging its important role in lifting barriers to entry for biotech and medtech scaleups in Australia and enabling the translation of research from bench to bedside.
Jointly funded by TRI and the Qld Govt, ENTRI will address a critical capability gap in Australia, enabling companies to access cGMP cleanrooms, the global gold standard for bio manufacturing.
"ENTRI will launch Queensland as the epicentre of biomanufacturing in Australia," Bleijie said.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Aug 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Aug 25
